BOSTON (AP) _ Akcea Therapeutics Inc. (AKCA) on Tuesday reported fourth-quarter net income of $82.4 million, after reporting a loss in the same period a year earlier.

The Boston-based company said it had profit of 86 cents per share.

The biopharmaceutical company posted revenue of $277.5 million in the period.

For the year, the company reported net income of $40.8 million, or 48 cents per share, swinging to a profit in the period. Revenue was reported as $488.5 million.

Akcea Therapeutics shares have increased nearly 1% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.10, a drop of 46% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKCA at https://www.zacks.com/ap/AKCA

Automated Insights, source Associated Press News